SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-014686
Filing Date
2024-05-08
Accepted
2024-05-08 19:58:23
Documents
1
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3656
  Complete submission text file 0001127602-24-014686.txt   5162
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Issuer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432
Business Address
ISHRAK OMAR (Reporting) CIK: 0001523102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37702 | Film No.: 24928069